Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

$1.87
-0.01 (-0.53%)
NASDAQ
USD, US
Medical - Diagnostics & Research

52 Week Range

1.76-37.8

Beta

4.69

Market Cap

$5.83M

Last Dividend

0

PE (TTM)

-0.39

Dividend Yield (TTM)

0

Price Chart

Industry

Medical - Diagnostics & Research

Sector

Healthcare

CEO

Mr. Harry Simeonidis

Full-Time Employees

51

IPO Date

2020-12-23

Description

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Phone

646 828 8258

Address

142 West 57th Street, New York, NY, 10019, US

CIK

0001725430